Middle East Pharmaceutical Industries Co.

Last Updated:
  • 130.80 SAR
  • -1.80
  • -1.36%
شركة الشرق الأوسط للصناعات الدوائية
أفالون فارما
Symbol : 4016
ISIN : SA160G51UO10
52-Week Range : 90.20 - 197.60
Turnover Ratio : 2.23
Market : Saudi Exchange
Sector : Pharma, Biotech & Life Science
Industry : Health Care Supplies
Sub-Industry :

Basic Information

  • Activity :
    Middle East Pharmaceutical Industries Co. (known as: AVALON PHARMA) is a public company, listed on Saudi Exchange “Tadawul” (TDWL) since Februry 2024. AVALON PHARMA operats within the pharmaceuticals Research...
  • Industry Group :
    Health care supplies & services
  • Sub-Industry :
  • ISIN :
    SA160G51UO10
  • Contact Person :
  • Established On:
    29-Jun-1998
  • Stock Listing On :
    27-Feb-2024
  • No of Employees :
    535 Employees as of 2023
  • Outstanding Shares :
    20,000,000
  • Free Float Shares :
  • Par Value :
  • Paid Capital :
  • Market Cap :
  • Authorized Capital :

Indices Membership

Action Date Index Provider
Join 2024 Pharma, Biotech & Life Science Saudi Exchange Co
Join 2024 Tadawul All Share Index (TASI) Saudi Exchange Co
Middle East Pharmaceutical Industries Co.
Second Industrial City, PO Box 3800, Riyadh 14331, Kingdom of Saudi Arabia
T : +966 11 2653948
F : +966 11 2654723
www.avalonpharmaceutical.com
investor.relations@avalon.com.sa

Management

Title Name As Of
Chairman: Ahmed Altabbaa 2022
Deputy Chairman: Hisham Attar 2023
Managing Director: Mohammed Al Ghannam 2022
Board Member: Faisal Aljaman 2022
Omar Al Jaroudi 2023

Reports

Date Title File
2024 AVALON PHARMA Quarterly Financials Report Q2 2024
2024 AVALON PHARMA Quarterly Financials Report Q1 2024
2024 Avalon delivers strong start to 2024 with a remarkable 37% increase in revenue, high profitability and substantial rise in net profit
2024 AVALON PHARMA Annual Financials Report 2023
2024 Middle East Pharmaceutical Industries Company(“Avalon Pharma”) Announces the Final Offer Price
2024 Middle East Pharmaceutical Industries Company(“Avalon Pharma”) Announces its IPO Offer Price Range and Commencement of Institutional Book Building
2024 Middle East Pharmaceutical Industries Company (“Avalon Pharma”) Announces its Intention to Float on the Saudi Exchange’s Main Market
2023 AVALON PHARMA Quarterly Financials Report Q2 2023
2023 AVALON PHARMA Annual Financials Report 2022
2022 AVALON PHARMA Annual Financials Report 2021
2021 AVALON PHARMA Annual Financials Report 2020
Check our coverage for